Matrix-bound nanovesicles prevent ischemia-induced retinal ganglion cell axon degeneration and death and preserve visual function
Open Access
- 5 March 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 3482
Abstract
Injury to retinal ganglion cells (RGC), central nervous system neurons that relay visual information to the brain, often leads to RGC axon degeneration and permanently lost visual function. Herein this study shows matrix-bound nanovesicles (MBV), a distinct class of extracellular nanovesicle localized specifically to the extracellular matrix (ECM) of healthy tissues, can neuroprotect RGCs and preserve visual function after severe, intraocular pressure (IOP) induced ischemia in rat. Intravitreal MBV injections attenuated IOP-induced RGC axon degeneration and death, protected RGC axon connectivity to visual nuclei in the brain, and prevented loss in retinal function as shown by histology, anterograde axon tracing, manganese-enhanced magnetic resonance imaging, and electroretinography. In the optic nerve, MBV also prevented IOP-induced decreases in growth associated protein-43 and IOP-induced increases in glial fibrillary acidic protein. In vitro studies showed MBV suppressed pro-inflammatory signaling by activated microglia and astrocytes, stimulated RGC neurite growth, and neuroprotected RGCs from neurotoxic media conditioned by pro-inflammatory astrocytes. Thus, MBV can positively modulate distinct signaling pathways (e.g., inflammation, cell death, and axon growth) in diverse cell types. Since MBV are naturally derived, bioactive factors present in numerous FDA approved devices, MBV may be readily useful, not only experimentally, but also clinically as immunomodulatory, neuroprotective factors for treating trauma or disease in the retina as well as other CNS tissues.Keywords
Funding Information
- United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (W81XWH-15-1-0026, W81XWH-15-1-0026)
This publication has 61 references indexed in Scilit:
- Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protectionFrontiers in Cellular Neuroscience, 2013
- Hydrogels derived from central nervous system extracellular matrixBiomaterials, 2013
- KLF Family Members Regulate Intrinsic Axon Regeneration AbilityScience, 2009
- Extracellular matrix as a biological scaffold material: Structure and functionActa Biomaterialia, 2009
- Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR PathwayScience, 2008
- Combinatorial treatments for promoting axon regeneration in the CNS: Strategies for overcoming inhibitory signals and activating neurons' intrinsic growth stateDevelopmental Neurobiology, 2007
- Functional Characterization of Retina and Optic Nerve after Acute Ocular Ischemia in RatsInvestigative Ophthalmology & Visual Science, 2003
- Gap‐43 immunoreactivity and axon regeneration in retinal ganglion cells of the ratJournal of Neurobiology, 1994
- Peripheral nerve implantation into a penetrating lesion of the eye: Stimulation of the damaged retinaBrain Research, 1986
- The structure of batrachotoxinin A, a novel steroidal alkaloid from the Columbian arrow poison frog, Phyllobates aurotaeniaJournal of the American Chemical Society, 1968